The use of sunitinib in renal cell carcinoma: where are we now?

Czarnecka, Anna M

The use of sunitinib in renal cell carcinoma: where are we now? [electronic resource] - Expert review of anticancer therapy Sep 2014 - 983-99 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

1744-8328

10.1586/14737140.2014.941815 doi


Angiogenesis Inhibitors--adverse effects
Animals
Antineoplastic Agents--adverse effects
Carcinoma, Renal Cell--drug therapy
Disease-Free Survival
Humans
Indoles--adverse effects
Kidney Neoplasms--drug therapy
Neoplasm Metastasis
Pyrroles--adverse effects
Sunitinib